华北制药：获得腺苷钴胺胶囊（0.5mg）的《药品注册证书》

Core Insights - North China Pharmaceutical (600812.SH) has received the drug registration certificate for Adenosylcobalamin capsules (0.5mg) from the National Medical Products Administration, indicating the product's compliance with basic procurement bidding conditions and its efficacy equivalent to the original product [2] Company Summary - The newly approved product is primarily used for the prevention and treatment of vitamin B12 deficiency, which is increasingly needed when dietary intake is insufficient, as well as for megaloblastic anemia [2] - The approval effectively enhances the company's product pipeline in blood and hematopoietic system medications [2] - However, the sales of formulation products are subject to uncertainties due to potential changes in domestic pharmaceutical industry policies and market conditions [2]